Physician profile
Tracey Lakin
NPI 1215042494
$3,948.03
in general payments reported to CMS, 2019-2025
34 companies · $631 in 2025
The $631 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $459 · 2020: $117 · 2021: $394 · 2022: $814 · 2023: $957 · 2024: $575 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,162.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $694.56 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $523.04 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $405.94 | 2019-2025 | Veozah |
| Mayne Pharma Commercial LLC | $306.00 | 2021-2025 | |
| Pfizer INC. | $186.86 | 2019-2023 | |
| Therapeuticsmd, INC. | $176.80 | 2019-2022 | |
| Myovant Sciences INC. | $158.13 | 2021-2022 | |
| Organon LLC | $151.35 | 2022-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $144.45 | 2024-2025 | Fluent Fluid Management System, Myosure Tissue Removal Device, Omni Hysteroscope |
| Exeltis, USA INC. | $126.50 | 2019-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $116.81 | 2022-2025 | |
| Intuitive Surgical, INC. | $93.20 | 2022 | |
| Sage Therapeutics, LLC | $86.62 | 2019-2024 | |
| Vertex Pharmaceuticals Incorporated | $70.84 | 2025 | |
| Allergan, INC. | $70.36 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $65.40 | 2019-2020 | |
| Millicent US INC | $61.89 | 2024-2025 | Femring, Intrarosa, Femlyv |
| Coopersurgical, INC. | $59.92 | 2025 | Sos, Paragard T 380a |
| Agile Therapeutics, INC. | $59.67 | 2021-2024 | Twirla |
| Minerva Surgical, INC | $56.55 | 2023 | |
| Conmed Corporation | $47.15 | 2022-2025 | Airseal |
| Avion Pharmaceuticals | $40.62 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $33.41 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $29.92 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $26.00 | 2019 | |
| Covidien LP | $25.30 | 2019 | |
| Urovant Sciences INC | $21.82 | 2022 | |
| Novo Nordisk INC | $20.43 | 2025 | |
| Exact Sciences Corporation | $17.90 | 2023 | Cologuard Collection Kit |
| Axonics, INC. | $16.26 | 2024 | Bulkamid |
| Meditrina | $15.83 | 2023 | |
| Coloplast Corp | $13.89 | 2024 | |
| Acessa Health INC. | $12.94 | 2019 | |
| Medtronic, INC. | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracey Lakin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.